{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:16:10Z","timestamp":1774127770252,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-025-00550-8","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:27:14Z","timestamp":1755199634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Baculovirus-mediated production and purification of ferritin nanoparticles for rift valley fever vaccine development"],"prefix":"10.1186","volume":"19","author":[{"given":"Margarida Q.","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"Ashni","family":"Tambaclal","sequence":"additional","affiliation":[]},{"given":"Brian","family":"Kloss","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","volume":"13","author":"DM Smith","year":"2013","unstructured":"Smith DM, Simon JK, Baker JR Jr. Applications of nanotechnology for immunology. Nat Rev Immunol. 2013;13:592\u2013605.","journal-title":"Nat Rev Immunol"},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","volume":"298","author":"C Foged","year":"2005","unstructured":"Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 2005;298:315\u201322.","journal-title":"Int J Pharm"},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/pharmaceutics13101621","volume":"13","author":"MQ Rodrigues","year":"2021","unstructured":"Rodrigues MQ, Alves PM, Rold\u00e3o A. Functionalizing ferritin nanoparticles for vaccine development. Pharmaceutics. 2021;13:1621.","journal-title":"Pharmaceutics"},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, et al. Peptide Tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci. 2012;109:E690\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed. 2001;40:2004\u201321.","journal-title":"Angew Chem Int Ed"},{"key":"550_CR6","first-page":"1608","volume":"35","author":"MQ Rodrigues","year":"2024","unstructured":"Rodrigues MQ, Pat\u00e3o S, Thomaz M, Nunes T, Alves PM, Rold\u00e3o A. Tyrosinase-Mediated conjugation for antigen display on ferritin nanoparticles. Bioconjug Chem. 2024;35:1608\u201317.","journal-title":"Bioconjug Chem"},{"key":"550_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/ind.2006.2.143","volume":"2","author":"CQ Li","year":"2006","unstructured":"Li CQ, Soistman E, Carter DC. Ferritin nanoparticle technology\u2026 A new platform for antigen presentation and vaccine development. Ind Biotechnol. 2006;2:143\u20137.","journal-title":"Ind Biotechnol"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo M, Wei C-J, Yassine HM, McTamney PM, Boyington JC, Whittle JRR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102\u20136.","journal-title":"Nature"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine HM, Boyington JC, McTamney PM, Wei C-J, Kanekiyo M, Kong W-P, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med. 2015;21:1065\u201370.","journal-title":"Nat Med"},{"key":"550_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","volume":"28","author":"KV Houser","year":"2022","unstructured":"Houser KV, Chen GL, Carter C, Crank MC, Nguyen TA, Burgos Florez MC, et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nat Med. 2022;28:383\u201391.","journal-title":"Nat Med"},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JRR, Baxa U, et al. Rational design of an Epstein-Barr virus vaccine targeting the Receptor-Binding site. Cell. 2015;162:1090\u2013100.","journal-title":"Cell"},{"key":"550_CR12","doi-asserted-by":"publisher","first-page":"110143","DOI":"10.1016\/j.celrep.2021.110143","volume":"37","author":"MG Joyce","year":"2021","unstructured":"Joyce MG, Chen W-H, Sankhala RS, Hajduczki A, Thomas PV, Choe M, et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Rep. 2021;37:110143.","journal-title":"Cell Rep"},{"key":"550_CR13","doi-asserted-by":"publisher","first-page":"eaay7199","DOI":"10.1126\/science.aay7199","volume":"366","author":"KO Saunders","year":"2019","unstructured":"Saunders KO, Wiehe K, Tian M, Acharya P, Bradley T, Alam SM, et al. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science. 2019;366:eaay7199.","journal-title":"Science"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","volume":"9","author":"Y-S Kim","year":"2018","unstructured":"Kim Y-S, Son A, Kim J, Kwon SB, Kim MH, Kim P, et al. Chaperna-Mediated assembly of Ferritin-Based middle East respiratory Syndrome-Coronavirus nanoparticles. Front Immunol. 2018;9:1093.","journal-title":"Front Immunol"},{"key":"550_CR15","first-page":"107","volume":"2","author":"A Monie","year":"2008","unstructured":"Monie A, Hung C-F, Roden R, Wu T-C. Cervarix\u2122: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biol Targets Ther. 2008;2:107\u201313.","journal-title":"Biol Targets Ther"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/2051013615595595","volume":"3","author":"MMJ Cox","year":"2015","unstructured":"Cox MMJ, Izikson R, Post P, Dunkle L. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults. Ther Adv Vaccines. 2015;3:97\u2013108.","journal-title":"Ther Adv Vaccines"},{"key":"550_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.biotechadv.2011.04.004","volume":"29","author":"C-Y Chen","year":"2011","unstructured":"Chen C-Y, Lin C-Y, Chen G-Y, Hu Y-C. Baculovirus as a gene delivery vector: recent Understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv. 2011;29:618\u201331.","journal-title":"Biotechnol Adv"},{"key":"550_CR18","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1073\/pnas.92.22.10099","volume":"92","author":"C Hofmann","year":"1995","unstructured":"Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci. 1995;92:10099\u2013103.","journal-title":"Proc Natl Acad Sci"},{"key":"550_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/156652405774962263","volume":"5","author":"R Flick","year":"2005","unstructured":"Flick R, Bouloy M. Rift Valley fever virus. Curr Mol Med. 2005;5:827\u201334.","journal-title":"Curr Mol Med"},{"key":"550_CR20","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3201\/eid1712.111035","volume":"17","author":"AA Grobbelaar","year":"2011","unstructured":"Grobbelaar AA, Weyer J, Leman PA, Kemp A, Paweska JT, Swanepoel R. Molecular epidemiology of rift Valley fever virus. Emerg Infect Dis. 2011;17:2270\u20136.","journal-title":"Emerg Infect Dis"},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"7346294","DOI":"10.1155\/2016\/7346294","volume":"2016","author":"M Alhaj","year":"2016","unstructured":"Alhaj M. Safety and efficacy profile of commercial veterinary vaccines against rift Valley fever: A review study. J Immunol Res. 2016;2016:7346294.","journal-title":"J Immunol Res"},{"key":"550_CR22","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/vaccines10111794","volume":"10","author":"PK Kitandwe","year":"2022","unstructured":"Kitandwe PK, McKay PF, Kaleebu P, Shattock RJ. An overview of rift Valley fever vaccine development strategies. Vaccines. 2022;10:1794.","journal-title":"Vaccines"},{"key":"550_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1128\/jvi.64.4.1549-1555.1990","volume":"64","author":"JA Suzich","year":"1990","unstructured":"Suzich JA, Kakach LT, Collett MS. Expression strategy of a phlebovirus: biogenesis of proteins from the rift Valley fever virus M segment. J Virol. 1990;64:1549\u201355.","journal-title":"J Virol"},{"key":"550_CR24","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.isci.2020.101669","volume":"23","author":"D Wright","year":"2020","unstructured":"Wright D, Allen ER, Clark MHA, Gitonga JN, Karanja HK, Hulswit RJG, et al. Naturally acquired rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein. iScience. 2020;23:101669.","journal-title":"iScience"},{"key":"550_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1006\/jmbi.1995.0274","volume":"248","author":"J Trikha","year":"1995","unstructured":"Trikha J, Theil EC, Allewell NM. High resolution crystal structures of amphibian Red-Cell L ferritin: potential roles for structural plasticity and solvation in function. J Mol Biol. 1995;248:949\u201367.","journal-title":"J Mol Biol"},{"key":"550_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","volume":"390","author":"KJ Cho","year":"2009","unstructured":"Cho KJ, Shin HJ, Lee J-H, Kim K-J, Park SS, Lee Y, et al. The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake. J Mol Biol. 2009;390:83\u201398.","journal-title":"J Mol Biol"},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0042-6822(85)90320-4","volume":"144","author":"MS Collett","year":"1985","unstructured":"Collett MS, Purchio AF, Keegan K, Frazier S, Hays W, Anderson DK, et al. Complete nucleotide sequence of the M RNA segment of rift Valley fever virus. Virology. 1985;144:228\u201345.","journal-title":"Virology"},{"key":"550_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/vaccines9030301","volume":"9","author":"PJ Wichgers Schreur","year":"2021","unstructured":"Wichgers Schreur PJ, Tacken M, Gutjahr B, Keller M, van Keulen L, Kant J, et al. Vaccine efficacy of Self-Assembled multimeric protein scaffold particles displaying the glycoprotein Gn head domain of rift Valley fever virus. Vaccines. 2021;9:301.","journal-title":"Vaccines"},{"key":"550_CR29","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1093\/nar\/18.20.6069","volume":"18","author":"C Aslanidis","year":"1990","unstructured":"Aslanidis C, de Jong PJ. Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res. 1990;18:6069\u201374.","journal-title":"Nucleic Acids Res"},{"key":"550_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.mie.2021.12.008","volume":"671","author":"B Kloss","year":"2022","unstructured":"Kloss B. Genomics-based strategies toward the identification of a Z-ISO carotenoid biosynthetic enzyme suitable for structural studies. Methods Enzymol. 2022;671:171\u2013205.","journal-title":"Methods Enzymol"},{"key":"550_CR31","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/nprot.2014.173","volume":"9","author":"A Goehring","year":"2014","unstructured":"Goehring A, Lee C-H, Wang KH, Michel JC, Claxton DP, Baconguis I, et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat Protoc. 2014;9:2574\u201385.","journal-title":"Nat Protoc"},{"key":"550_CR32","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1128\/jvi.67.8.4566-4579.1993","volume":"67","author":"VA Luckow","year":"1993","unstructured":"Luckow VA, Lee SC, Barry GF, Olins PO. Efficient generation of infectious Recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol. 1993;67:4566\u201379.","journal-title":"J Virol"},{"key":"550_CR33","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1128\/JVI.00194-13","volume":"87","author":"Y-R Chen","year":"2013","unstructured":"Chen Y-R, Zhong S, Fei Z, Hashimoto Y, Xiang JZ, Zhang S, et al. The transcriptome of the baculovirus autographa Californica multiple nucleopolyhedrovirus in trichoplusia Ni cells. J Virol. 2013;87:6391\u2013405.","journal-title":"J Virol"},{"key":"550_CR34","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1128\/JVI.02243-14","volume":"88","author":"Y-R Chen","year":"2014","unstructured":"Chen Y-R, Zhong S, Fei Z, Gao S, Zhang S, Li Z, et al. Transcriptome responses of the host trichoplusia Ni to infection by the baculovirus autographa Californica multiple nucleopolyhedrovirus. J Virol. 2014;88:13781\u201397.","journal-title":"J Virol"},{"key":"550_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1472-6750-10-50","volume":"10","author":"Y Hashimoto","year":"2010","unstructured":"Hashimoto Y, Zhang S, Blissard GW. Ao38, a new cell line from eggs of the black Witch moth, Ascalapha odorata (Lepidoptera: Noctuidae), is permissive for AcMNPV infection and produces high levels of recombinant proteins. BMC Biotechnol. 2010;10:50.","journal-title":"BMC Biotechnol"},{"key":"550_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6750-12-12","volume":"12","author":"Y Hashimoto","year":"2012","unstructured":"Hashimoto Y, Zhang S, Zhang S, Chen Y-R, Blissard GW. Erratum to: BTI-Tnao38, a new cell line derived from trichoplusia ni, is permissive for AcMNPV infection and produces high levels of Recombinant proteins. BMC Biotechnol. 2012;12:12.","journal-title":"BMC Biotechnol"},{"key":"550_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2144\/03342bm05","volume":"34","author":"JA Mena","year":"2003","unstructured":"Mena JA, Ram\u00edrez OT, Palomares LA. Titration of Non-Occluded baculovirus using a cell viability assay. Biotechniques. 2003;34:260\u20134.","journal-title":"Biotechniques"},{"key":"550_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jviromet.2009.03.007","volume":"159","author":"A Rold\u00e3o","year":"2009","unstructured":"Rold\u00e3o A, Oliveira R, Carrondo MJT, Alves PM. Error assessment in Recombinant baculovirus titration: evaluation of different methods. J Virol Methods. 2009;159:69\u201380.","journal-title":"J Virol Methods"},{"key":"550_CR39","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31:3784\u20138.","journal-title":"Nucleic Acids Res"},{"key":"550_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1128\/jvi.58.2.263-270.1986","volume":"58","author":"K Keegan","year":"1986","unstructured":"Keegan K, Collett MS. Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of rift Valley fever virus. J Virol. 1986;58:263\u201370.","journal-title":"J Virol"},{"key":"550_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"550_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14:290\u20136.","journal-title":"Nat Methods"},{"key":"550_CR43","doi-asserted-by":"publisher","first-page":"908509","DOI":"10.3389\/fbioe.2022.908509","volume":"10","author":"R Correia","year":"2022","unstructured":"Correia R, Fernandes B, Castro R, Nagaoka H, Takashima E, Tsuboi T, et al. Asexual Blood-Stage malaria vaccine candidate PfRipr5: enhanced production in insect cells. Front Bioeng Biotechnol. 2022;10:908509.","journal-title":"Front Bioeng Biotechnol"},{"key":"550_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1472-6750-8-42","volume":"8","author":"N Kumar","year":"2008","unstructured":"Kumar N, Gammell P, Meleady P, Henry M, Clynes M. Differential protein expression following low temperature culture of suspension CHO-K1 cells. BMC Biotechnol. 2008;8:42.","journal-title":"BMC Biotechnol"},{"key":"550_CR45","doi-asserted-by":"publisher","first-page":"e0123562","DOI":"10.1371\/journal.pone.0123562","volume":"10","author":"C-Y Lin","year":"2015","unstructured":"Lin C-Y, Huang Z, Wen W, Wu A, Wang C, Niu L. Enhancing protein expression in HEK-293 cells by Lowering culture temperature. PLoS ONE. 2015;10:e0123562.","journal-title":"PLoS ONE"},{"key":"550_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/bp025609d","volume":"19","author":"Y-C Hu","year":"2003","unstructured":"Hu Y-C, Tsai C-T, Chang Y-J, Huang J-H. Enhancement and prolongation of Baculovirus-Mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog. 2003;19:373\u20139.","journal-title":"Biotechnol Prog"},{"key":"550_CR47","doi-asserted-by":"publisher","unstructured":"Correia R, Zotler T, Ferraz F, Fernandes B, Gra\u00e7a M, Pijlman GP et al. Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors. Biotechnol Bioeng [Internet]. [cited 2025 Mar 1];n\/a. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/bit.28925","DOI":"10.1002\/bit.28925"},{"key":"550_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/v16030426","volume":"16","author":"M Toth","year":"2024","unstructured":"Toth M, Reithofer M, Dutra G, Pereira Aguilar P, D\u00fcrauer A, Grabherr R. Comprehensive comparison of baculoviral and plasmid gene delivery in mammalian cells. Viruses. 2024;16:426.","journal-title":"Viruses"},{"key":"550_CR49","doi-asserted-by":"publisher","first-page":"832931","DOI":"10.3389\/fphar.2022.832931","volume":"13","author":"Y Miyauchi","year":"2022","unstructured":"Miyauchi Y, Kimura A, Sawai M, Fujimoto K, Hirota Y, Tanaka Y, et al. Use of a Baculovirus-Mammalian cell expression-System for expression of Drug-Metabolizing enzymes: optimization of infection with a focus on cytochrome P450 3A4. Front Pharmacol. 2022;13:832931.","journal-title":"Front Pharmacol"},{"key":"550_CR50","first-page":"100003","volume":"1","author":"Y Zhai","year":"2019","unstructured":"Zhai Y, Zhang D, Yu L, Sun F, Sun F. SmartBac, a new baculovirus system for large protein complex production. J Struct Biol X. 2019;1:100003.","journal-title":"J Struct Biol X"},{"key":"550_CR51","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jbiotec.2008.04.006","volume":"135","author":"B Jardin","year":"2008","unstructured":"Jardin B, Zhao Y, Selvaraj M, Montes J, Tran R, Prakash S, et al. Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a Hollow fiber bioreactor system. J Biotechnol. 2008;135:272\u201380.","journal-title":"J Biotechnol"},{"key":"550_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/v14030636","volume":"14","author":"E Puente-Massaguer","year":"2022","unstructured":"Puente-Massaguer E, Cajamarca-Berrezueta B, Volart A, Gonz\u00e1lez-Dom\u00ednguez I, G\u00f2dia F. Transduction of HEK293 cells with BacMam baculovirus is an efficient system for the production of HIV-1 Virus-like particles. Viruses. 2022;14:636.","journal-title":"Viruses"},{"key":"550_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/vim.2011.0016","volume":"24","author":"X-C Tang","year":"2011","unstructured":"Tang X-C, Lu H-R, Ross TM. Baculovirus-Produced influenza Virus-like particles in mammalian cells protect mice from lethal influenza challenge. Viral Immunol. 2011;24:311\u20139.","journal-title":"Viral Immunol"},{"key":"550_CR54","doi-asserted-by":"crossref","unstructured":"Hu L, Li Y, Ning Y-J, Deng F, Vlak JM, Hu Z et al. The Major Hurdle for Effective Baculovirus Transduction into Mammalian Cells Is Passing Early Endosomes. Shisler JL, editor. J Virol. 2019;93:e00709-19.","DOI":"10.1128\/JVI.00709-19"},{"key":"550_CR55","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1128\/JVI.02517-09","volume":"84","author":"S Dong","year":"2010","unstructured":"Dong S, Wang M, Qiu Z, Deng F, Vlak JM, Hu Z, et al. Autographa Californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pH. J Virol. 2010;84:5351\u20139.","journal-title":"J Virol"},{"key":"550_CR56","doi-asserted-by":"publisher","first-page":"8830","DOI":"10.1128\/JVI.00880-06","volume":"80","author":"G Long","year":"2006","unstructured":"Long G, Pan X, Kormelink R, Vlak JM. Functional entry of baculovirus into insect and mammalian cells is dependent on Clathrin-Mediated endocytosis. J Virol. 2006;80:8830\u20133.","journal-title":"J Virol"},{"key":"550_CR57","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/hum.1997.8.17-2011","volume":"8","author":"J Barsoum","year":"1997","unstructured":"Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a Recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther. 1997;8:2011\u20138.","journal-title":"Hum Gene Ther"},{"key":"550_CR58","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/pharmaceutics14040854","volume":"14","author":"B Fernandes","year":"2022","unstructured":"Fernandes B, Castro R, Bhoelan F, Bemelman D, Gomes RA, Costa J, et al. Insect cells for High-Yield production of SARS-CoV-2 Spike protein: Building a Virosome-Based COVID-19 vaccine candidate. Pharmaceutics. 2022;14:854.","journal-title":"Pharmaceutics"},{"key":"550_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pep.2019.04.001","volume":"160","author":"S-M Lee","year":"2019","unstructured":"Lee S-M, Plieskatt J, Krishnan S, Raina M, Harishchandra R, King CR. Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate. Protein Expr Purif. 2019;160:56\u201365.","journal-title":"Protein Expr Purif"},{"key":"550_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pep.2017.11.002","volume":"144","author":"C Geisler","year":"2018","unstructured":"Geisler C, Jarvis DL. Adventitious viruses in insect cell lines used for Recombinant protein expression. Protein Expr Purif. 2018;144:25\u201332.","journal-title":"Protein Expr Purif"},{"key":"550_CR61","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.vaccine.2019.10.083","volume":"38","author":"M Klausberger","year":"2020","unstructured":"Klausberger M, Leneva IA, Egorov A, Strobl F, Ghorbanpour SM, Falynskova IN, et al. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP Preparation in limiting postinfluenza Staphylococcus aureus infections. Vaccine. 2020;38:859\u201367.","journal-title":"Vaccine"},{"key":"550_CR62","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41598-020-57761-w","volume":"10","author":"F Strobl","year":"2020","unstructured":"Strobl F, Ghorbanpour SM, Palmberger D, Striedner G. Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells. Sci Rep. 2020;10:1065.","journal-title":"Sci Rep"},{"key":"550_CR63","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1002\/jssc.201901215","volume":"43","author":"K Reiter","year":"2020","unstructured":"Reiter K, Pereira Aguilar P, Grammelhofer D, Joseph J, Steppert P, Jungbauer A. Separation of influenza virus-like particles from baculovirus by polymer-grafted anion exchanger. J Sep Sci. 2020;43:2270\u20138.","journal-title":"J Sep Sci"},{"key":"550_CR64","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10529-013-1429-6","volume":"36","author":"M Wilde","year":"2014","unstructured":"Wilde M, Klausberger M, Palmberger D, Ernst W, Grabherr R. Tnao38, high five and Sf9\u2014evaluation of host\u2013virus interactions in three different insect cell lines: baculovirus production and Recombinant protein expression. Biotechnol Lett. 2014;36:743\u20139.","journal-title":"Biotechnol Lett"},{"key":"550_CR65","doi-asserted-by":"publisher","first-page":"e01868","DOI":"10.1128\/mbio.01868-23","volume":"14","author":"D Kim","year":"2023","unstructured":"Kim D, Kim E, Kim S, Chung Y, Lai C-J, Cha I, et al. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets. mBio. 2023;14:e01868\u201323.","journal-title":"mBio"},{"key":"550_CR66","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/vaccines11040821","volume":"11","author":"A Pattnaik","year":"2023","unstructured":"Pattnaik A, Sahoo BR, Struble LR, Borgstahl GEO, Zhou Y, Franco R, et al. A ferritin Nanoparticle-Based Zika virus vaccine candidate induces robust humoral and cellular immune responses and protects mice from lethal virus challenge. Vaccines. 2023;11:821.","journal-title":"Vaccines"},{"key":"550_CR67","doi-asserted-by":"publisher","first-page":"942897","DOI":"10.3389\/fimmu.2022.942897","volume":"13","author":"AE Powell","year":"2022","unstructured":"Powell AE, Xu D, Roth GA, Zhang K, Chiu W, Appel EA, et al. Multimerization of Ebola gp\u2206mucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies. Front Immunol. 2022;13:942897.","journal-title":"Front Immunol"},{"key":"550_CR68","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/vaccines12050546","volume":"12","author":"ND Salinas","year":"2024","unstructured":"Salinas ND, Ma R, McAleese H, Ouahes T, Long CA, Miura K, et al. A Self-Assembling Pfs230D1-Ferritin nanoparticle vaccine has potent and durable malaria Transmission-Reducing activity. Vaccines. 2024;12:546.","journal-title":"Vaccines"},{"key":"550_CR69","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41467-023-37417-9","volume":"14","author":"PA-B Weidenbacher","year":"2023","unstructured":"Weidenbacher PA-B, Sanyal M, Friedland N, Tang S, Arunachalam PS, Hu M, et al. A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nat Commun. 2023;14:2149.","journal-title":"Nat Commun"},{"key":"550_CR70","doi-asserted-by":"publisher","first-page":"e2316960121","DOI":"10.1073\/pnas.2316960121","volume":"121","author":"D Xu","year":"2024","unstructured":"Xu D, Powell AE, Utz A, Sanyal M, Do J, Patten JJ, et al. Design of universal Ebola virus vaccine candidates via Immunofocusing. Proc Natl Acad Sci U S A. 2024;121:e2316960121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"550_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jbiotec.2016.06.029","volume":"233","author":"F Monteiro","year":"2016","unstructured":"Monteiro F, Bernal V, Chaillet M, Berger I, Alves PM. Targeted supplementation design for improved production and quality of enveloped viral particles in insect cell-baculovirus expression system. J Biotechnol. 2016;233:34\u201341.","journal-title":"J Biotechnol"},{"key":"550_CR72","doi-asserted-by":"publisher","unstructured":"Fernandes B, Sousa M, Castro R, Sch\u00e4fer A, Hauser J, Schulze K et al. Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate. Front Bioeng Biotechnol [Internet]. 2022 [cited 2025 Jul 16];10. Available from: https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/https:\/\/doi.org\/10.3389\/fbioe.2022.879078\/full","DOI":"10.3389\/fbioe.2022.879078\/full"},{"key":"550_CR73","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/bit.27766","volume":"118","author":"B Fernandes","year":"2021","unstructured":"Fernandes B, Correia R, Sousa M, Carrondo MJT, Alves PM, Rold\u00e3o A. Integrating high cell density cultures with adapted laboratory evolution for improved Gag-HA virus-like particles production in stable insect cell lines. Biotechnol Bioeng. 2021;118:2536\u201347.","journal-title":"Biotechnol Bioeng"},{"key":"550_CR74","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1021\/acsinfecdis.7b00192","volume":"4","author":"IS Georgiev","year":"2018","unstructured":"Georgiev IS, Joyce MG, Chen RE, Leung K, McKee K, Druz A, et al. Two-Component ferritin nanoparticles for multimerization of diverse trimeric antigens. ACS Infect Dis. 2018;4:788\u201396.","journal-title":"ACS Infect Dis"},{"key":"550_CR75","doi-asserted-by":"publisher","first-page":"eaba6466","DOI":"10.1126\/sciimmunol.aba6466","volume":"5","author":"KA Swanson","year":"2020","unstructured":"Swanson KA, Rainho-Tomko JN, Williams ZP, Lanza L, Peredelchuk M, Kishko M, et al. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Sci Immunol. 2020;5:eaba6466\u20136466.","journal-title":"Sci Immunol"},{"key":"550_CR76","doi-asserted-by":"publisher","first-page":"eaaz6225","DOI":"10.1126\/sciadv.aaz6225","volume":"6","author":"L He","year":"2020","unstructured":"He L, Tzarum N, Lin X, Shapero B, Sou C, Mann CJ, et al. Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines. Sci Adv. 2020;6:eaaz6225\u20136225.","journal-title":"Sci Adv"},{"key":"550_CR77","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","volume":"7","author":"AE Powell","year":"2021","unstructured":"Powell AE, Zhang K, Sanyal M, Tang S, Weidenbacher PA, Li S, et al. A single immunization with Spike-Functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice. ACS Cent Sci. 2021;7:183\u201399.","journal-title":"ACS Cent Sci"},{"key":"550_CR78","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1038\/ncomms12041","volume":"7","author":"L He","year":"2016","unstructured":"He L, de Val N, Morris CD, Vora N, Thinnes TC, Kong L, et al. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nat Commun. 2016;7:12041\u201312041.","journal-title":"Nat Commun"},{"key":"550_CR79","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/pharmaceutics14091902","volume":"14","author":"D Li","year":"2022","unstructured":"Li D, Song H, Li J, Liu X, Gao X, Wu T, et al. Expression and evaluation of a novel PPRV nanoparticle antigen based on ferritin Self-Assembling technology. Pharmaceutics. 2022;14:1902.","journal-title":"Pharmaceutics"},{"key":"550_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.procbio.2023.03.026","volume":"129","author":"X Liu","year":"2023","unstructured":"Liu X, Song H, Jiang J, Gao X, Yi Y, Shang Y, et al. Baculovirus-expressed self-assembling SARS-CoV-2 nanoparticle vaccines targeting the S protein induce protective immunity in mice. Process Biochem Barking Lond Engl. 2023;129:200\u20138.","journal-title":"Process Biochem Barking Lond Engl"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-025-00550-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:10:35Z","timestamp":1756901435000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/s13036-025-00550-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1186\/s13036-025-00550-8","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to provide additional funding information, that had previously been omitted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}